牙周炎
炎症
医学
小静脉
内皮
内皮干细胞
病理
转录组
蛋白质组学
细胞
内皮功能障碍
细胞生物学
生物
氧化应激
发病机制
小动脉
免疫学
癌症研究
慢性牙周炎
调解人
牙龈和牙周袋
作者
Quinn T. Easter,Khoa Huynh,Camila S. Stolf,Jialiu Xie,Bruno Fernandes Matuck,Akira Hasuike,Zabdiel Alvarado‐Martinez,William S. Kim,Zhaoxu Chen,Apoena Aguiar Ribeiro,Nivedita Pareek,M. Andrea Azcárate-Peril,Di Wu,Renato Côrrea Viana Casarin,Kang I. Ko,Jinze Liu,Kevin M. Byrd
标识
DOI:10.1038/s41467-026-72452-2
摘要
Oral inflammatory diseases affect nearly half of all humans, yet mechanisms underlying rapidly-destructive inflammation remain poorly understood. We compared peri-implantitis with moderate- and high-grade periodontitis using integrated microbial and single-cell sequencing (>967,169-cells; single-cell RNA-seq, spatial proteotranscriptomics). Laser capture microdissection with compartmental microbiome analysis revealed reduced bacterial load and diversity in peri-implantitis. Expansion of the Human Periodontal Atlas with peri-implantitis single-cell RNA-seq data (36-samples; 121,395 cells) identified CD34+ vascular endothelial cell (VEC) rarefaction and oxidative stress, hypoxia, and NAD⁺ metabolism-associated transcriptional programs enriched in a TNFRSF6B⁺/ICAM1⁺ post-capillary venule (PC-VEC) subpopulation. NAD⁺-consuming ectoenzyme CD38 was selectively enriched and orthogonally confirmed by spatial transcriptomics (6-samples; 283,377-cells) and proteomics (23-samples; 562,397-cells). Spatial neighborhood analyses demonstrated CD38⁺-high PC-VEC expansion, closer proximity, and higher IL16–CD4 T cell signaling in peri-implantitis. Matched high-grade periodontitis biopsies confirmed spatially restricted CD38⁺-VECs despite similar microbial burden, identifying endothelial vasculopathy underlying rapidly advancing oral inflammation and a potential therapeutic axis. Oral inflammatory diseases affect nearly half of all people, yet rapid progression drivers are unclear. The study identified CD38+ endothelial cell dysfunction and vascular remodeling as key features of aggressive oral inflammation.
科研通智能强力驱动
Strongly Powered by AbleSci AI